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Abstract
Background
People with multimorbidity have reduced functional capacity, lower quality of life, higher
mortality rates and use healthcare resources more intensively than healthy people or those
with a single chronic condition. Multimorbidity was defined as the coexistence of two or
more chronic conditions in the same person. The aim of this study was to explore associa-
tions between multimorbidity and use of healthcare services and the impact of socioeco-
nomic status on utilization of hospitalizations and bed days.
Methods
The study population included all individuals aged 16 years and older who lived in the Capi-
tal Region of Denmark on January 1st, 2012. Data on chronic conditions, use of healthcare
services and demographics were obtained from Danish national administrative and health
registries. Zero-inflated models were used to calculate anticipated annual use of hospitaliza-
tions and bed days.
Findings
The study population comprised 1,397,173 individuals; the prevalence of multimorbidity was
22%. Prevalence was inversely related to educational attainment. For people with multimor-
bidity, utilization of hospitalizations and bed days increased approximately linearly with the
number of chronic conditions. However, a steep increase in utilization of bed days was
observed between five and six or more chronic conditions. An educational gradient in hospi-
talization rates and use of bed days was observed regardless of the number of chronic con-
ditions. Educational attainment was strongly associated with healthcare utilization.
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Conclusion
Multimorbidity was associated with a significant increase in utilization of all healthcare ser-
vices in Denmark. In addition, a socioeconomic gradient was observed in utilization of hospi-
talizations and bed days.
Introduction
Multimorbidity is often defined as the coexistence of two or more chronic conditions in the
same person [1, 2]. People with multimorbidity have decreased functional competence [3],
lower quality of life [4], higher mortality rates [5] and use healthcare resources more inten-
sively than healthy people or those with just one chronic condition [6]. Most diseases and con-
sequences of poor health are unequally distributed among socioeconomic population groups,
and socioeconomic differences are obvious in the prevalence and consequences of multimor-
bidity [7, 8]. The prevalence of multimorbidity is increasing internationally. The overall preva-
lence of multimorbidity in Ontario, Canada increased in nearly all age groups, reflecting a 40%
total increase between 2003 and 2009 from 17.4% to 24.3% [9]. A study from the Netherlands
reported an increase in multimorbidity prevalence from 12.7% to 16.2% between 2004 and
2011 [10]. An American study showed that the prevalence of multimorbidity rose between
2000 and 2010 from 22% to 30%, a trend that was most pronounced among people younger
than age 65 [11]. Expected continuing increases in the prevalence of multimorbidity are recog-
nized as a major public health and healthcare challenge for modern societies [9].
To understand the healthcare challenges associated with multimorbidity, the impact of
multimorbidity on healthcare utilization must be carefully assessed [12, 13]. However, detailed
knowledge about how multimorbidity affects healthcare utilization is incomplete. A systematic
review identified 35 studies investigating relationships between multimorbidity and healthcare
utilization, healthcare costs, or both. All included studies showed a positive correlation
between multimorbidity and at least one aspect of utilization (physician visits and hospital
care) and costs (medications, out-of-pocket spending, and total healthcare costs) for elderly
populations [14]. The included studies were from the United States (23), Europe (5), Canada
(4), Asia (2), and Australia (1). Many of these study populations were large enough to enable
sophisticated statistical analyses, and four were large cross-sectional studies that included from
1.13 million to 1.65 million people [15–17]. Regrettably, these large studies had varying inclu-
sion criteria, and none reported sociodemographic data that are necessary for exploring possi-
ble associations between multimorbidity, healthcare utilization, and sociodemographic status.
Synthesis of the studies was not possible due to ambiguous definitions and measurements of
multimorbidity, as well as a multitude of healthcare utilization outcomes.
After publication of this systematic review, several large-scale studies stating the association
between multimorbidity and utilization of services has been published [18–25]. Studies explor-
ing the relationship between healthcare utilization and the number of chronic conditions dem-
onstrated that additional factors affect utilization include age [18, 19], gender [18, 19],
impaired activities of daily life [20], and socioeconomic status [19]. Furthermore, the impact
of multimorbidity on healthcare utilization has been shown to differ across individual factors,
disease combinations, healthcare systems, and regions [22, 26]. A study examining the associa-
tion between multimorbidity, income and hospital admissions reported that poorer people in
Scotland and Hong Kong were more likely to be admitted to hospitals while in China poorer
people showed the opposite association [22].
Multimorbidity and healthcare utilization
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The Danish healthcare system is based on universal coverage and principles of free and
equal access to healthcare for all citizens. Information on the impact of multimorbidity on
healthcare utilization in the Danish healthcare system is sparse. To the best of our knowledge,
only a single study to date has demonstrated that hospitalizations, use of bed days and general
practitioner (GP) visits, were significantly higher for patients with multimorbidity, compared
with those who had no chronic conditions [27].
The aim of this study was to explore associations between multimorbidity and healthcare
utilization and the impact of socioeconomic status on utilization of hospitalizations and bed
days. The structure and content of Danish healthcare registers provide a unique opportunity
to quantify how these variables interact [28, 29], which we explored in a large-scale, cross-sec-
tional, regional, register-based population study.
Methods
Study population and data sources
The study population included all individuals aged 16 years and older who lived in the Capital
Region of Denmark on January 1st, 2012. The included 1,397,173 individuals represented
approximately one-third of the entire Danish adult population. Data on chronic conditions,
use of healthcare services, and demographics, including gender, age, and educational attain-
ment, were obtained from Danish national administrative and health registries: the Danish
National Patient Registry [30], the Danish National Prescription Registry [31], the Danish
National Health Service Registry [32], and The National Diabetes Registry [33]. All data
obtained from registries were merged at the level of individuals using their unique social secu-
rity numbers. However, national registries do not provide data on conditions diagnosed in the
primary care sector. In addition to data on diagnoses of chronic conditions available from the
secondary healthcare sector, diagnostic algorithms developed by the Research Center for Pre-
vention and Health at Glostrup University Hospital were used to identify primary sector diag-
noses of 16 chronic conditions of interest for the entire population (Table 1). Algorithms used
to define the 16 conditions, see S1 Table [6]. Details about the diagnostic algorithms are
Table 1. Chronic conditions included in definition of multimorbidity (N = 16).
Allergies
Hypertension
High cholesterol
Diabetes (type 1 and type 2)
Heart disease
Stroke
Back pain
Joint disease
Osteoarthritis
Osteoporosis
Chronic obstructive pulmonary disease
Cancer
Dementia
Anxiety
Long-term use of antidepressants
Schizophrenia
https://doi.org/10.1371/journal.pone.0214183.t001
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provided elsewhere [7]. Multimorbidity was defined as two or more chronic conditions occur-
ring simultaneously in the same person.
Because data on direct costs could not be linked to the study data, we identified utilization
of hospitalizations and bed days, which are among the most expensive services in healthcare,
as proxies for direct costs. Hospitalizations are including both acute and planned hospitaliza-
tions, and bed days both acute and planned bed days. Socioeconomic status was evaluated in
the educational dimension, defined as highest educational achievement and grouped into four
categories according to the length of education: none (primary school) (�10 years), short (11–
14 years), medium (14–17 years), and long (�17 years) [34]. A considerable amount of indi-
viduals were not recorded with any level of education (5.9%). The group proved homogeneous
and statistically indistinguishable from the group with ‘no education’. As these data are not
self-reported but register data, it was decided to include them in the analyses, labeling them
with a specific level of education, different from ‘none’. Finally, we also recorded healthcare
utilization for emergency department visits, outpatient visits, GP visits, out-of-hour GP visits,
yearly control visits in general practice, and specialist visits. All quantitative data were accumu-
lated over the year 2012.
Statistical analysis
Descriptive statistics were calculated for gender, age, and educational attainment by the num-
ber of chronic conditions. Means for each type of healthcare utilization were calculated. Logis-
tic regression was used to calculate odds ratios (ORs) for healthcare utilization for individuals
with multimorbidity versus individuals with none and with one chronic condition. ORs were
calculated in both a raw form and adjusted for gender, age, and educational attainment.
Hospitalizations and bed days were adjusted for emergency visits, out-patient visits, GP vis-
its, out-of-hours GP visits, yearly controls in general practice, private specialist visits, number
of conditions, age, gender, cohabitation status, education attainment, and employment status.
This was accomplished by applying zero-inflated models to both proxies. The models were
used to calculate anticipated annual use of hospitalizations and bed days within educational
attainment groups, separately for each number of chronic conditions.
The decision to use zero-inflated models was prompted by the fact that many individuals
do not use bed days or hospitalization [35]. To counter extreme values for some covariates,
squared effects of all numerical covariates were included as explanatory variables. For the par-
tial model (1) below, a squared effect of GP visits was not included due to convergence prob-
lems. For the partial models of the form (2) below, quadrupled effects of ambulatory visits and
out-of-hours GP visits were included. The zero-inflated model was applied as follows.
First, the probability p of having at least one bed day/one hospitalization was modeled with
a logistic regression model,
logitðpiÞ ¼
X26
j¼1
ajxji; i ¼ 1; . . . ; n; ð1Þ
where pi is the probability of one or more hospitalizations or bed days for an individual i and
xj is the jth covariate derived from the specified explanatory variables. Subsequently, numbers
of bed days and hospitalizations y were similarly modeled with a log-linear model,
logðyiÞ ¼
X29
j¼1
bjxji þ εi; i ¼ 1; . . . ; n1; ð2Þ
where n1� n is the number of individuals with at least one bed day or hospitalization. In the
models (2), two observations of bed days and three observations of hospitalizations were omit-
ted as outliers for the analysis of bed days and hospitalizations, respectively.
Multimorbidity and healthcare utilization
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For scenarios in which a specific number of conditions and a specific level of education
were assumed, the linear predictors Z^ ¼
P
a^ jxj and l^ ¼
P
b^ jxj were calculated, with all other
covariates kept at the empirical mean for the group with the specified number of conditions
and level of education. Estimated responses were found as y^ ¼ logit  1ðZ^Þexpðl^ þ s^2=2Þ,
where σ2 is the variance of l^, thus combining models (1) and (2). All analyses were carried out
using R software version 3.5.0 (34).
Ethics approval
Approval to conduct the study was obtained from the Danish Data Protection Agency. No
informed consent was required.
Results
Among 1,397,173 individuals included in the study population, approximately half (720,885;
52%) were women, the majority (927,568; 66%) had none or short education, and the preva-
lence of multimorbidity was 22% (301,757). Table 2 shows the distribution of gender, age, and
educational attainment by the number of chronic conditions. The prevalence of both one and
two or more chronic conditions was significantly higher for women than for men. Overall,
multimorbidity was highest among individuals 65–84 years old, followed by those who were
45–64 years old. Educational attainment was inversely related to multimorbidity.
Mean rates of healthcare utilization among people with multimorbidity were much higher
than among people with no chronic conditions, by a factor of 1.73 to 9.67, depending on the
type of utilization (Table 3). When comparing people with multimorbidity and those with one
chronic condition, rates of healthcare utilization were 1.44 to 4.00 times higher for those with
multimorbidity. In both comparisons, the largest between-group difference was for yearly con-
trol visits in general practice. Unadjusted and adjusted ORs for all types of healthcare utiliza-
tion were significantly bigger than 1 (p<0.001) when comparing people with multimorbidity,
to people with zero or one chronic condition. Unadjusted ORs for healthcare utilization for
Table 2. Distributions of the study population (N = 1,397,173) by gender, age, and educational attainment and number of chronic conditions, N (%).
Number of chronic conditions
0
N = 809,920
1
N = 285,496
� 2
N = 301,757
Gender
Male 418,105 (62) 127,591 (19) 130,592 (19)
Female 391,815 (54) 157,905 (22) 171,165 (24)
Age in years
16–24 170,486 (86) 25,768 (13) 1,770 (1)
25–44 385,540 (77) 89,216 (18) 23,557 (5)
45–64 205,947 (48) 111,147 (26) 110,949 (26)
65–84 45,529 (19) 53,334 (22) 140,001 (59)
>84 2,418 (7) 6,031 (18) 25,480 (75)
Education
None (� 10 years) 185,347 (53) 69,779 (20) 93,702 (27)
Short (11–14 years) 325,241 (56) 123,439 (22) 130,420 (23)
Medium (15–16 years) 132,531 (59) 49,576 (22) 41,536 (19)
Long (� 17 years) 107,578 (65) 34,035 (21) 22,174 (14)
Missing 59,233 (72) 8,667 (11) 13,925 (17)
https://doi.org/10.1371/journal.pone.0214183.t002
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people with multimorbidity vs. people with no chronic conditions were from1.65 to 11.76, and
from 1.31 to 3.15 vs. people with one chronic condition (Table 3). Adjusted ORs for healthcare
utilization for people with multimorbidity vs. people with no chronic conditions were from
1.86 to 6.70, and from 1.44 to 2.94 vs. people with one chronic condition (Table 3).
Among people with multimorbidity, utilization of hospitalizations increased approximately
linearly with the number of chronic conditions. In Fig 1A, hospitalization rates are indicated
with a black line; the reference regression line in red has a slope equal to the mean number of
hospitalizations across the number of chronic conditions. The similarity between observed
rates and the regression line indicates that each chronic condition corresponded to an average
of approximately 0.24 hospitalizations per year. A similar pattern was observed for bed days
(Fig 1B). For people with five or fewer chronic conditions, the utilization of bed days was
approximately proportional to the number of conditions. However, between five and six or
more chronic conditions, a steep increase in utilization of bed days was observed. Among indi-
viduals with six or more chronic conditions, utilization was higher than the mean number of
bed days per condition multiplied by the number of conditions.
Figs 2 and 3 depict utilization of hospitalization and bed days stratified by educational
attainment. An educational gradient in hospitalization rates was observed across one to six or
more chronic conditions (Fig 2). Hospitalizations were more frequent in individuals with
shorter education, compared with those with longer education. For bed day utilization (Fig 3),
individuals with no education exhibited the highest estimated utilization rates, regardless of
the number of chronic conditions.
Discussion
The study aimed to explore associations between multimorbidity and healthcare utilization
and the impact of socioeconomic status on service use utilization. The study showed that
healthcare utilization rates were higher in people with multimorbidity, independent of type of
utilization. Hospitalization rates increased approximately linearly with number of chronic
conditions and bed days use, though in people with six and more conditions bed days use
increased steeply. Hospitalization rates increased by number of chronic conditions and was
more frequent in people with shorter education. For bed days individuals with no education
had the highest utilization rates regardless of number of chronic conditions.
This study is the first large-scale, register-based study investigating associations between
multimorbidity and utilization of healthcare services in the secondary and primary sectors in
Table 3. Mean and odds ratios (ORs) for healthcare utilization among individuals with 0, 1, and� 2 chronic conditions.
Number of chronic conditions
0 1 � 2 � 2 vs. 0 � 2 vs. 1
Mean Unadjusted OR Adjusted OR� Unadjusted OR Adjusted OR�
Hospitalizations 0.12 0.22 0.51 3.84 (3.80–3.88) 2.78 (2.74–2.83) 2.26 (2.23–2.29) 1.77 (175–1.80)
Bed days 0.31 0.82 2.65 3.84 (3.80–3.88) 2.78 (2.74–2.85) 2.26 (2.23–2.29) 1.77 (1.75–1.80)
Emergency visits 0.15 0.18 0.26 1.65 (1.63–1.66) 1.86 (1.83–1.88) 1.39 (1.37–1.41) 1.49 (1.47–1.52)
Outpatient visits 0.91 1.88 3.86 4.83 (4.79–4.87) 3.79 (3.76–3.84) 2.25 (2.23–2.29) 2.03 (2.01–2.05)
General practice visits 4.34 7.39 12.94 8.37 (8.31–8.44) 6.70 (6.64–6.76) 3.15 (3.13–3.18) 2.94 (2.91–2.27)
Out-of-hours general practice visits 0.28 0.38 0.56 1.66 (1.64–1.67) 2.23 (2.19–2.26) 1.31 (1.29–1.32) 1.59 (1.57–1.61)
Yearly control visits in general practice 0.03 0.12 0.29 11.76 (11.58–11.96) 5.66 (5.56–5.77) 2.86 (2.81–2.89) 1.96 (1.93–1.98)
Specialist visits 0.69 1.39 2.09 3.66 (3.63–3.69) 2.36 (2.34–2.39) 1.77 (1.75–1.79) 1.44 (1.43–1.45)
�Adjusted for gender, age, and educational attainment
https://doi.org/10.1371/journal.pone.0214183.t003
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Denmark. In this study we were able to obtain a medical diagnosis for all diseased adults in the
Capital Region aged 16 and above using algorithmic diagnoses for 16 conditions. This con-
trasts with studies using register-based diagnoses that only included patients who had had a
hospital admission or were affiliated with an outpatient clinic. Although the 16 selected condi-
tions do not represent the full spectrum of chronic disease, they include highly prevalent
chronic conditions. A similar study from Scotland [36] included 40 conditions and revealed
an age-stratified pattern of prevalence of chronic conditions nearly identical to that of the data
reported here [7, 36]. This suggests that the 16 included diagnoses in this study encompass all
conditions and combinations of conditions that are predominant at the population level.
The prevalence of multimorbidity in our study was 22% [7]. Females had a 10% overrepre-
sentation among individuals with multimorbidity (Table 2). However, in this study the over-
representation of women among multimorbid individuals cannot be explained by the
longevity of women alone: Gathering centenarians, the frequency of multimorbidity within
each one-year age group was consistently higher for women than men in 83 out of 85 one-year
age groups, the difference increasing with high age. This phenomenon is consistent with previ-
ous results across healthcare systems and geography [37–39]. Eighty percent of the study popu-
lation and 45% of individuals with multimorbidity were younger than age 65 (Table 2). The
study of multimorbidity is often confined to adults aged 65 and up [19, 40–42]. However,
younger individuals with multimorbidity who survive will age into this group and can be
Fig 1. Relationship between numbers of chronic conditions and hospitalizations (1A) and between numbers of chronic conditions and bed days
(1B). (1A) The black line indicates the observed number of hospitalizations by the number of chronic conditions. The red line indicates the reference
regression line that shows the mean number of hospitalizations multiplied by the number of chronic conditions. (1B) The black line indicates the
observed number of bed days by number of chronic conditions. The red line indicates the reference regression line that shows the mean number of bed
days multiplied by the numbers of chronic conditions.
https://doi.org/10.1371/journal.pone.0214183.g001
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expected to have higher lifelong healthcare utilization. In fact, we observed that, compared to
age-similar individuals without chronic conditions, younger multimorbid individuals had a
relatively higher rate of bed day utilization than did older individuals with multimorbidity.
This finding highlights the importance of understanding chronic illness and healthcare utiliza-
tion of younger multimorbid persons.
Utilization vs. number of conditions
The consistency of increases in healthcare utilization for individuals with multimorbidity,
compared to those without chronic conditions, is remarkable (Table 3). The use of all services
was higher to a statistically significant degree. Excluding hospitalizations and bed days, the
increase in utilization rates for individuals with multimorbidity ranged from 73% (emergency
department visits) to 324% (outpatient visits), except for yearly control visits in general prac-
tice, which were 867% higher. Disregarding the latter due to very low utilization rates, the aver-
age increase in healthcare utilization was 180% for individuals with multimorbidity, compared
to those with no chronic conditions. The corresponding average increase in utilization rates
for multimorbid individuals, compared with those with one chronic disease, was 65%. Unad-
justed ORs for healthcare utilization for individuals with multimorbidity, compared with those
with no chronic conditions, were all statistically significant and ranged from 1.65 (95% confi-
dence interval [CI], 1.63–1.66) for emergency department visits and 11.76 (95% CI, 11.58–
11.96) for yearly control visits. When adjusted for gender, age, and educational attainment,
utilization differences were less pronounced, ranging from 1.86 (95% CI, 1.83–1.88) for
Fig 2. Number of chronic conditions associated with the modeled rate of hospitalizations by educational attainment levels. Black line, no
education; red line, short education; green line, medium education; blue line, long education.
https://doi.org/10.1371/journal.pone.0214183.g002
Multimorbidity and healthcare utilization
PLOS ONE | https://doi.org/10.1371/journal.pone.0214183 August 1, 2019 8 / 15
emergency department visits to 6.70 (95% CI, 6.64–6.76) for GP visits. A similar but less pro-
nounced pattern was seen when comparing multimorbid individuals to those with one chronic
disease (Table 3). These results demonstrate that the impact of multimorbidity on healthcare
utilization applies to a range of services and varies relatively little. Healthcare utilization rates
were 2–4 times higher than those for people without chronic conditions. The direct relation-
ship between the number of chronic conditions and healthcare utilization is well-documented
in the literature [14, 26, 27, 43, 44], but, to the best of our knowledge, the impact of multimor-
bidity on a broad spectrum of healthcare utilizations has not been documented previously.
The approximately linear relationship between frequency of hospitalizations and the num-
ber of chronic conditions depicted in Fig 1A also applies to the relationship between bed days
and the number of chronic conditions in Fig 1B for five or fewer conditions. When the num-
ber of conditions increases to six or more, the utilization of bed days increases by a factor
greater than the average impact of a single condition. The overall utilization pattern is that
each condition corresponds to 0.24 hospitalizations and 0.92 bed days, while the length of each
hospitalization is longer for individuals with six or more conditions. The slope of the curve for
six or more conditions increases twofold to 1.84 (Fig 1B). The fact that the regression coeffi-
cient no longer explains the frequency of bed days per chronic condition leads us to define
individuals with six or more conditions as high utilizers; they make up 0.87% of the population
but account for 7.29% of bed days. An earlier Danish study found that 5% of the population
with chronic conditions accounted for 45% of healthcare expenses [45]. This finding is in
line with a large US study that showed that 5% of high utilizers accounted for up to 47% of
Fig 3. Number of chronic conditions associated with the modeled rate of bed days by educational attainment. Black line, no education; red line,
short education; green line, medium education; blue line, long education.
https://doi.org/10.1371/journal.pone.0214183.g003
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healthcare costs [46]. A recent German study reported two subgroups of high utilizers: the
oldest patients who suffered from severe multimorbidity and younger elderly patients with
psychiatric or psychosomatic conditions [43]. Further research is required to examine charac-
teristics and utilization of the high utilizers identified in this study.
Fig 1A shows a decline in utilization between nine and ten or more conditions. A possible
explanation is that individuals with a very high disease burden have higher mortality, while those
who survive have lower healthcare utilization than expected. Only 43 individuals had ten or
more diagnosed conditions, and small sample size effects may also contribute to this finding.
Socioeconomic status
We found that the prevalence of multimorbidity decreased with increasing educational attain-
ment, revealing a pronounced and statistically significant inverse socioeconomic gradient.
This is consistent with previous findings [7].
To study the impact of multimorbidity on healthcare costs, we adjusted data for proxy costs
for different educational attainment groups with varying profiles in terms of age, gender, other
healthcare utilization and level of multimorbidity. When adjusted for these effects, as described
in the methods statistical section, a clear inverse social gradient in hospitalization utilization
appeared (Fig 2). Adjusted hospitalization utilization decreased as the level of educational
attainment increased, generally irrespective of the number of chronic conditions. However,
adjusted bed-day utilization revealed a slightly different pattern. An educational gradient no
longer appeared; curves for short, medium, and high educational attainment tended to over-
lap. However, the group with no educational attainment stood out by virtue of higher health-
care utilization than the others. One important feature is that the relative difference between
utilization rates for individuals with no education and those in other educational groups
appeared close to constant across the number of chronic conditions.
In general, the number of hospitalizations decreased with increasing level of educational
attainment. For multimorbid individuals, the length of each hospitalization was longer for
individuals without any education than for those with at least some education. The reason
for this finding is unknown. It may be the case that chronic disease tends to be more severe
among individuals without education and that longer hospitalizations are caused by non-
chronic conditions not included in our study. In addition, one could posit that different spec-
tra of chronic conditions occur for persons with and without education, but investigation of
this supposition will require further research. Other factors affecting the higher healthcare uti-
lization rate observed in people with lower education attainment include lower health literacy
levels linked to lower education attainment [47]. Disease burden has been shown to be associ-
ated with lower education levels in type 2 diabetes, and this may apply to other chronic condi-
tions [48]. Furthermore, people with none or low educational attainment often has weak social
networks and proper discharge to home might demand coordinated preparation that rely, in
part, on support from individual’s own social support structure [49]. However, we currently
lack a well-founded explanation for differences in the two adjusted proxies for general utiliza-
tion of healthcare services.
Strengths and limitations
The major strength of our study is that it is a large-scale register-based study, including com-
prehensive information about chronic conditions, healthcare utilization, and educational
attainment of the complete population of the Capital Region of Denmark aged 16 years and
above. Generally, data from the Danish national registers provide complete information about
healthcare system contacts, are of high quality and reliability, and are used extensively in
Multimorbidity and healthcare utilization
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research [28, 50]. As a general population-based study, our findings reflect the actual situation
in a real-world setting. Based on register data, our study was free of recall bias and there was
no loss of follow up.
Several limitations of our study deserve consideration. The study is designed as a cross-sec-
tional observational study which does not allow cause-effect conclusions from study results.
The necessary use of diagnostic algorithms to identify patients with chronic conditions in
the primary healthcare sector is an approximation of actual diagnoses. Although the diagnostic
algorithms have been shown to be highly accurate [6], they are not clinically determined by
physicians. The study was based on cross-sectional data collected during a single year, and the
number of patients with specific chronic conditions may be underestimated [51, 52]. In addi-
tion, we were not able to include healthcare services provided in the municipalities. Scarce reg-
ister data exist for municipality services; existing data are not well defined and thus not useful
for research purposes. Inclusion of the data on utilization of community healthcare services
would likely have helped to generate a more complete picture of healthcare utilization related
to multimorbidity. The model formulae (1) and (2) are given without interactions terms. A
large number of relevant interactions could be considered. However, because of the large num-
ber of individuals studied, even microscopic effects (or model misspecifications) will trigger a
statistical significance, and we have found that the relevance of a top-down approach to model-
ing would be misleading. Similarly, including few targeted interactions might be seen as (and
may be) selective, and indeed, we believe, unnecessary for this study: The large number of cor-
related covariates in the models will to some extent compensate for a relevant covariate not
included. This has been investigated for interaction terms between education and number of
conditions, and education and age, where the deviation of results (in terms of pendants to Figs
2 and 3) has been miniscule. Finally, 6% of our population did not have information on educa-
tional attainment. This information appeared to be missing at random, except for individuals
aged 91 years and above; Danish administrative registers only contain information on educa-
tion for individuals born since 1921 [34]. However, this group contained few individuals, and
we estimated the effect of these missing data to be minimal and possible changes in parameter
estimates therefore very small.
Comparison to other studies on multimorbidity in populations should be performed with
care. Varying definitions of multimorbidity (i.e., two or more chronic conditions), included
conditions, and data collection methods render comparisons difficult. However, these chal-
lenges may be overcome for large studies [36].
Conclusion
Multimorbidity is associated with a significant increase in utilization of all healthcare services
in Denmark. The association between utilization and socioeconomic gradient is important
and well-described. Nevertheless, the increasing utilization of bed days in patients with six and
more chronic conditions is interesting, and a deeper understanding of this observation might
point to possible preventive services with impact of this overutilization. The result that patients
younger than 65 years has a more intensive utilization pattern than older patients should be
studied to disclose a possible underlying mechanism that might point towards effective pre-
ventive services. Further research could be directed towards quantifying which combinations
of diseases and disease portfolios, that drives the healthcare utilization. A possible approach
could be cluster analysis, grouping similar disease portfolios in the same cluster, and radically
different disease portfolios in different clusters. Cluster-wise healthcare utilization and rela-
tions to high utilizers and age may improve our knowledge on how complex disease portfolios
impact healthcare utilization.
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